Additionally, the 36-month beta value for ELDN is 0.99. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELDN is 22.85M and currently, short sellers hold a 0.47% ratio of that float. The average trading volume of ELDN on April 19, 2024 was 71.09K shares.
ELDN) stock’s latest price update
Eledon Pharmaceuticals Inc (NASDAQ: ELDN)’s stock price has soared by 26.75 in relation to previous closing price of 1.57. Nevertheless, the company has seen a gain of 19.88% in its stock price over the last five trading days. GlobeNewsWire reported 2023-11-29 that IRVINE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C.
ELDN’s Market Performance
Eledon Pharmaceuticals Inc (ELDN) has experienced a 19.88% rise in stock performance for the past week, with a 22.84% rise in the past month, and a 22.09% rise in the past quarter. The volatility ratio for the week is 13.31%, and the volatility levels for the past 30 days are at 10.32% for ELDN. The simple moving average for the past 20 days is 9.70% for ELDN’s stock, with a 31.43% simple moving average for the past 200 days.
Analysts’ Opinion of ELDN
Many brokerage firms have already submitted their reports for ELDN stocks, with Cantor Fitzgerald repeating the rating for ELDN by listing it as a “Overweight.” The predicted price for ELDN in the upcoming period, according to Cantor Fitzgerald is $15 based on the research report published on May 13, 2022 of the previous year 2022.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see ELDN reach a price target of $25. The rating they have provided for ELDN stocks is “Overweight” according to the report published on March 23rd, 2021.
ELDN Trading at 12.65% from the 50-Day Moving Average
After a stumble in the market that brought ELDN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.54% of loss for the given period.
Volatility was left at 10.32%, however, over the last 30 days, the volatility rate increased by 13.31%, as shares surge +17.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.94% upper at present.
During the last 5 trading sessions, ELDN rose by +19.88%, which changed the moving average for the period of 200-days by +42.14% in comparison to the 20-day moving average, which settled at $1.8290. In addition, Eledon Pharmaceuticals Inc saw 10.56% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ELDN
The total capital return value is set at -0.35. Equity return is now at value -48.12, with -36.88 for asset returns.
Based on Eledon Pharmaceuticals Inc (ELDN), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -103.2. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is 127.22.
Currently, EBITDA for the company is -42.63 million with net debt to EBITDA at 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.41.
Conclusion
In conclusion, Eledon Pharmaceuticals Inc (ELDN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
